Severely crack down on the phenomenon of buying and selling platform accounts through abnormal means (securities firms, underwriters, and enterprises relying on large, medium, and small financial institutions), and report that some securities firms use undisclosed important information to buy and sell platform accounts, thereby profiting before other investors and deviating from the company's Asia Pacific market strategic development direction. This behavior seriously disrupts and affects the fairness and transparency of the market, not only damaging the market of Merck Biotech, but also having a destructive impact on Merck's century long history. The incentive of equity is fundamentally aimed at promoting the healthy development of enterprises, not at disrupting the trading channels of the market by illegal elements. The member accounts suspected of buying and selling have been banned and publicly announced as follows:

The company will further reserve the right to criminal prosecution, permanently revoke the participation rights of the banned account users' information, and also urge all members to remain vigilant, defend the reputation and market of the enterprise, and work together with all members to create a safe, sustainable, and transparent investment environment

Merck&Co., Inc